Navigation Links
Chickenpox Shot Provides Long-Term Protection, Study Finds

By Serena Gordon
HealthDay Reporter

TUESDAY, April 2 (HealthDay News) -- The chickenpox vaccine is very effective at preventing the disease, and its protection doesn't wane over time, new research finds.

"This is a really good vaccine," said the study's lead author, Dr. Roger Baxter, co-director of the Vaccine Study Center at Kaiser Permanente in Oakland, Calif. One dose is enough to protect against most cases and severe infection, he said, while "the second dose just wipes it out."

The study results were released online April 1 in advance of publication in the May print issue of Pediatrics.

Chickenpox, an infection caused by the varicella virus, was commonplace in childhood until the introduction of the vaccine in the United States in 1995. Prior to the vaccine's introduction, more than 90 percent of children contracted chickenpox by the time they were 20 years old, according to the study. Although usually mild, the disease, which causes itchy blisters all over the body, was responsible for about 100 deaths a year.

When the vaccine was introduced, it wasn't clear if one dose would be sufficient, or if protection would wear off over time. Consistent protection was important because chickenpox infection in older teens and adults can be much more serious than it generally is in childhood, Baxter said.

Initial studies suggested the vaccine was between 80 percent and 90 percent effective, but sporadic outbreaks of chickenpox still occurred. In 2006, the Advisory Committee on Immunization Practices recommended that a second dose of varicella vaccine be given when children are between 4 and 6 years old.

The current study included 7,585 children vaccinated with varicella vaccine in 1995 when they were 2 years old. The researchers followed the children's health for 14 years, looking for cases of chickenpox or herpes zoster, which is more commonly known as shingles. Shingles is another type of infection caused by the chickenpox virus that tends to affect people later in life, according to the U.S. National Institute of Neurological Disorders and Stroke.

In that group of children, 2,826 also received a booster dose of varicella vaccine between 2006 and 2009.

Slightly more than 1,500 cases of breakthrough cases of chickenpox occurred during the study period. All of the cases occurred after the first dose of the vaccine. No breakthrough cases were reported after the second dose of vaccine, the study found.

Only 2 percent of the breakthrough cases were severe. Overall, the rate of chickenpox in vaccinated children was about 10 times lower than it would have been had they not been vaccinated, according to the study.

Shingles is unusual in children, but researchers estimated the children who were vaccinated had a 40 percent reduced risk of shingles.

Because breakthrough cases occurred soon after vaccination, it's possible that the second dose would be more effective if given earlier than the recommended age of 4 to 6 years, the authors noted.

Dr. Kenneth Bromberg, director of the Vaccine Research Center at the Brooklyn Hospital Center in New York City, commented favorably on the study.

"These researchers answered important questions about efficacy with one dose; it's about 90 percent, and the effectiveness of two doses seems to be about 100 percent," Bromberg said.

Both experts said it looks like this vaccine will continue to protect these children into adulthood, although no studies have yet confirmed these findings because the vaccine has only been available for 17 years.

With most vaccines, effectiveness wanes a little bit over time, said Baxter. "But with the varicella vaccine, it got more and more effective over time," he noted.

Will adults need another dose of vaccine? From this study, Bromberg said, "it looks promising that the answer will be no."

More information

Learn more about chickenpox and the vaccine from the U.S. Centers for Disease Control and Prevention.

SOURCES: Roger Baxter, M.D., co-director, Vaccine Study Center, Kaiser Permanente, Oakland, Calif.; Kenneth Bromberg, M.D., chairman, pediatrics, and director, Vaccine Research Center, the Brooklyn Hospital Center, New York City; May 2013, Pediatrics

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Chickenpox Cases Fall 80% Over Decade: CDC
2. Online Pilates Mat and Ball Training Provides Opportunity for Education, Income and Career Growth
3. New Merchant Solution Provides Credibility to Medical Marijuana Industry
4. Wake Forest Baptist research provides clues to alcohol addiction vulnerability
5. Now Provides Information on Rehabilitation Centers and Procedures
6. Online Insurance Marketplace Provides tips on how to Choose the best life Insurance Quotes
7. Combination therapy provides similar clinical benefit as single drug treatment in MS
8. Maui'd Forever The Hawaiian Island Wedding Planning Company Now Provides Activities to Their Clients
9. Oakland Spine & Rehabilitation Center Provides Effective Whiplash And Post-Surgery Physical Therapy
10. Astro Clairvoyant Norah Guide for Premium Astrology Now Provides Weekly Love Horoscopes and Love Tarot Readings at No Cost
11. New chemical probe provides tool to investigate role of malignant brain tumor domains
Post Your Comments:
Related Image:
Chickenpox Shot Provides Long-Term Protection, Study Finds
(Date:12/1/2015)... ... December 01, 2015 , ... World Patent Marketing ... Jar, a container patent that allows for easier packing and organizing of items into ... worth $90 billion," says Scott Cooper, CEO and Creative Director of World Patent Marketing ...
(Date:12/1/2015)... ... ... Tampa is the first health care provider in the region to offer the vBloc® ... a vagal blocking therapy, delivered via the Maestro® System, for the treatment of adult patients ... 40 to 45 kg, or a BMI of at least 35 to 39.9 kg with ...
(Date:12/1/2015)... ... ... Dr. Paul Vitenas, one of the top cosmetic surgeons in Texas ... the Best Single Physician Practice in the nation. Dr. Vitenas and his practice were ... the industry publication. , Dr. Vitenas said he was very honored to receive ...
(Date:12/1/2015)... , ... December 01, 2015 , ... ... the 7th Annual 2015 Golden Bridge Business Awards under the New Products and ... zero capex web based sample management software that helps labs organize ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... facilities, radiographic technicians must mark the film for accurate interpretation by the radiologist. ... of. Fortunately, an inventor from Sacramento, Calif., has found a way to alleviate ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... -- CytRx Corporation (NASDAQ: CYTR ), a biopharmaceutical ... that it has reached its enrollment target of 400 ... trial of aldoxorubicin in patients with previously treated soft ... in Q1 2016. The Phase 3 trial is a randomized, ... from the FDA at 79 sites in ...
(Date:12/1/2015)... 1, 2015   Craneware, Inc ., the ... today announced the company will showcase a new ... ® solution at the American Society for ... . The new features are focused on simplifying ... and managing enterprise-wide pharmacy charges to ensure compliance ...
(Date:12/1/2015)... Germany , December 1, 2015 /PRNewswire/ ... leading global manufacturer of eye and gaze tracking solutions, ... SMI remote eye trackers as a component of its ... concussions, eye sight, and medical and performance issues in ... part of SMI,s mass-market-ready eye tracking platform, which is ...
Breaking Medicine Technology: